## Abstract ## Background and Objectives Low tumor expression of the p27^Kip1^ protein, which is involved in cell cycle control and apoptosis, is considered a negative prognostic factor in different types of cancer. The aim of this study was to evaluate the clinical and pathological significance o
โฆ LIBER โฆ
Cytoplasmic Mislocalization of P27 Kip1 Protein is Associated With Poor Survival in Gastric Carcinoma
โ Scribed by Wen, Sicheng ;Singh, Kamaljeet ;Noble, Lelia ;Tavares, Rose ;Resnick, Murray ;Moss, Steven F.
- Book ID
- 122175491
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 66 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Low level of p27(Kip1) protein expressio
โ
Donato Nitti; Claudio Belluco; Enzo Mammano; Alberto Marchet; Alessandro Ambrosi
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 244 KB
Reduced selenium-binding protein 1 is as
โ
Jin Zhang; Wei-guo Dong; Jun Lin
๐
Article
๐
2010
๐
Springer US
๐
English
โ 327 KB
High cytoplasmic expression of p27Kip1 i
โ
Stephan Kruck; Axel S. Merseburger; Joerg Hennenlotter; Marcus Scharpf; Christia
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 473 KB
p27Kip1 loss does not predict survival i
โ
Roger M. Feakins; Hugh E. Mulcahy; Alberto Quaglia; Aida Jawhari; Zunwu Zhang; S
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 535 KB
428 Elevated Skp2 protein expression and
โ
J. Cheong; J. Kim; J. Lee; S. Lee; J. Hahn; Y. Ko; Y. Min
๐
Article
๐
2004
๐
Elsevier Science
๐
English
โ 137 KB
Expression of p27Kip1 and cyclin D1 prot
โ
Han, Sehwan; Kim, Hong-Yong; Park, Kyeongmee; Lee, Myung-Soo; Kim, Hong-Joo; Kim
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 318 KB
๐ 2 views
Background and Objectives: p27Kip1 is an inhibitor of cyclindependent kinases and is speculated to be a potential prognostic indicator in numerous human cancers. We investigated expression of p27Kip1 along with cyclin D1 in gastric cancer to estimate the clinical utility of p27Kip1. Methods: Immunoh